The Hymed Group Corporation


 

     hyCURE® - Medical Hydrolysate of Type I Collagen

                        powder.gif (30230 bytes)                

CASE STUDY: A.Z., 77 year old white female. Did not know she was diabetic. Admitted 1/29/97 with gangrenous right great toe and purple discoloration of entire foot except for 4 remaining toes.

1/29/97, 1/30/97, 1/31/97 Underwent debridement. Had amputation of first great toe on 2/3/97, with debridement of forefoot; wound almost 50% of length of foot, with 3 tendons of toes exposed on dorsal surface.

2/5/97 Started Mesalt to wound.

2/6/97 Went to extended care facility.

2/7/97 Area over tendon measured 7.5 cm long x 3.6 cm wide.

2/11/97 Mesalt stopped and hyCURE® started to wound at dorsum of foot. Mesalt used on plantar surface to continue debridement of thick yellow eschar.

2/12/97 Increased granulation tissue noted on dorsum wound bed.

2/17/97 Saw improvement with tissue covering tendons.

2/21/97 Grafting performed over tendons and closure of plantar area of foot.

"hyCURE® worked to promote the deposition of tissue over tendons to allow the physician to graft the site."

Edna Keister, BBA, RN, CETN, OCN

 

Send mail to Anita Petito with questions or comments about this web site.
Copyright © 1998, 1999, The Hymed Group, all rights reserved. Use of and access to the information contained on this site is subject to the terms of our Legal Notice.
Last modified: November 16, 1999